Post by
MarkAble on Jan 19, 2021 1:54pm
Potential revenue
The potential revenue and profit stream for THRM is extraordinary. Think of a 100 million tests a day at a dollar or two a test could generate. Covid and its variants/ mutations are going to make rapid testing a part of life worldwide for the next several years. Approvals for this are needed fast and once they happen THRM could be poised to make billions for its investors. Play the penny trading game if you wish but be sure to keep a mittfull of shares for the longer term.
Comment by
nrv090909 on Jan 19, 2021 1:55pm
plus after covid, the Asymtomatic tests will be useful patents on anything. Like I said Johnson and Johnson buy out, 20 Therma shares for 1 JNJ.